Home
  • Donate money to KEI
  • Listserves
  • Main Areas of Work
  • Events
  • Publications
  • Blogs
  • About KEI

Knowledge Ecology International

Attending and mending the knowledge ecosystem

Navigation

  • Site Map
  • Recent posts
  • Feed aggregator
  • Polls
  • Groups

Round II of the Paris Accord took place in Paris on October 23 and 24, 2009.

Book navigation

  • Right to Read for Persons with Reading Disabilities
  • About KEI
  • Access to Medical Technologies
  • Berne Convention Appendix Regarding Special Provisions Regarding Developing Countries
  • Competition Policy
  • Data points on prices of medical technologies
  • Databases
  • Enforcement and Remedies to Infringement
  • Events
  • General Access to Knowledge Issues
  • Government Funded Inventions
  • Knowledge Governance Fora
  • Main Areas of Work
  • Medical diseases, conditions and technologies
  • Nuclear Proliferation
  • Patent Policy
  • Prizes to stimulate innovation
  • Publications and Research Notes
  • Test Data
  • Timelines
  • Transparency

User login

What is OpenID?
  • Log in using OpenID
  • Cancel OpenID login
  • Create new account
  • Request new password
Home

ritonavir

Prices for Abbott's Norvir (generic name Ritonavir) as a Standalone Product in 2010

Submitted by Anne Mira Guha on 10. August 2010 - 14:09
  • Abbott
  • norvir
  • ritonavir
  • Medical Technologies

KEI Research Note 2010:4
August 12, 2010
Anne Mira Guha

Prices for Abbott's Norvir (generic name Ritonavir) as a Standalone Product in 2010

1. Introduction

  • Add new comment
  • Read more
Syndicate content

Support KEI

WASHINGTON 1621 Connecticut Ave. NW, Suite 500, Washington, DC 20009 /TEL: +1.202.332.2670 · FAX +1.202.332.2673 GENEVE 1 Route des Morillons, CP 2100, 1211 Genève 2, Switzerland TEL: +41.22.791.6727
THEME DESIGN Copyright © 2009 under GPL by Tribute Media. Site Powered by Drupal.